What are the DSM‑5 criteria for insomnia disorder?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

DSM-5 Diagnostic Criteria for Insomnia Disorder

According to DSM-5, insomnia disorder is diagnosed when a patient reports difficulty with sleep initiation, sleep maintenance, or early-morning awakening with inability to return to sleep, occurring at least 3 nights per week for at least 3 months, causing clinically significant distress or daytime impairment, despite adequate opportunity for sleep, and not better explained by another sleep, medical, mental, or substance-related disorder. 1

Core Diagnostic Requirements

A. Sleep Complaint (≥1 of the following)

  • Difficulty initiating sleep 1, 2
  • Difficulty maintaining sleep (frequent or prolonged nocturnal awakenings) 1, 2
  • Early-morning awakening with inability to return to sleep 1, 2
  • Chronically nonrestorative or poor-quality sleep 3

B. Adequate Sleep Opportunity

  • The sleep difficulty must occur despite having adequate opportunity and circumstances for sleep—meaning the patient has sufficient time allocated for sleep and an appropriate sleep environment 1, 2

C. Daytime Consequences (≥1 required)

  • Fatigue or malaise 3
  • Impaired attention, concentration, or memory 3
  • Social, vocational, educational, or behavioral dysfunction 3, 1
  • Mood disturbance or irritability 3
  • Daytime sleepiness 3
  • Reduced motivation, energy, or initiative 3
  • Proneness to errors or accidents at work or while driving 3
  • Tension headaches or gastrointestinal symptoms in response to sleep loss 3
  • Concerns or worries about sleep 3

D. Frequency and Duration Thresholds

  • Symptoms must occur at least 3 nights per week 1, 2
  • Duration must be at least 3 months for chronic insomnia disorder 1, 2
  • These quantitative thresholds reduce diagnostic variability and improve inter-rater reliability 4

E. Exclusion Criteria

  • The sleep disturbance is not better explained by another sleep disorder (e.g., obstructive sleep apnea, restless legs syndrome, circadian rhythm sleep-wake disorder, parasomnia) 1, 5
  • The insomnia does not occur exclusively during the course of another mental disorder 1
  • The insomnia is not attributable to the physiological effects of a substance (medication, drug of abuse) or another medical condition 1

Key Conceptual Changes in DSM-5

Elimination of Primary/Secondary Distinction

  • DSM-5 removed the outdated primary versus secondary insomnia classification, recognizing that insomnia is an independent disorder that may coexist with—but is not merely secondary to—medical or psychiatric conditions 2, 6, 7
  • Insomnia and comorbid conditions have a bidirectional, interactive relationship rather than a hierarchical cause-effect relationship 8, 2, 7
  • Clinicians should document insomnia disorder and any co-occurring psychiatric or medical diagnoses as separate, co-existing conditions 2

Unified Diagnostic Category

  • The term "Insomnia Disorder" consolidates previous subtypes (psychophysiological insomnia, paradoxical insomnia, idiopathic insomnia) into a single diagnostic category 2, 4
  • This harmonization across DSM-5, ICD-11, and ICSD-3 reduces diagnostic confusion and improves consistency 2, 4

Clinical Assessment Essentials

Minimum Documentation Required

  • A 2-week sleep diary documenting bedtime, sleep-onset latency, number and duration of awakenings, wake after sleep onset, time in bed, total sleep time, and sleep efficiency should be obtained before confirming diagnosis 4
  • Assessment must include evaluation of daytime functional impairment in social, occupational, educational, or behavioral domains 4
  • Screen for perpetuating factors including maladaptive sleep behaviors (excessive time in bed), dysfunctional beliefs about sleep ("I must get 8 hours or I'll be ruined"), and conditioned arousal 4

Differential Diagnosis Considerations

  • Persistent insomnia beyond 7–10 days of treatment warrants evaluation for comorbid sleep disorders such as obstructive sleep apnea, restless legs syndrome, periodic limb movement disorder, or circadian rhythm disorders 8, 4
  • Paradoxical insomnia (severe subjective complaint with minimal objective disturbance on polysomnography) requires different management than psychophysiological insomnia, though DSM-5 does not differentiate these presentations 4
  • Insomnia symptoms are common in other sleep disorders (e.g., sleep apnea, circadian rhythm disorders), making it sometimes difficult to determine whether the patient has insomnia disorder or whether symptoms are purely due to another sleep disorder 5

Diagnostic Limitations and Pitfalls

Lack of Phenotypic Specificity

  • DSM-5 criteria do not differentiate sleep-onset, sleep-maintenance, or early-morning awakening subtypes, which have distinct pharmacologic treatment implications (e.g., zaleplon for onset vs. doxepin for maintenance) 4

Absence of Severity Gradations

  • No formal mild, moderate, or severe ratings are provided based on frequency of affected nights or degree of daytime impairment 4

Reliance on Self-Report

  • Insomnia disorder diagnosis primarily rests on self-report; objective measures like actigraphy or polysomnography are not part of routine diagnostic criteria but play an important role in research and differential diagnosis 9

Special Population Considerations

  • ICD-11 emphasizes caregiver input when assessing insomnia in cognitively impaired adults and pediatric patients, a consideration not explicitly detailed in DSM-5 2

References

Guideline

Evolution of Insomnia Diagnostic Criteria and Clinical Implications (cited)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

clinical guideline for the evaluation and management of chronic insomnia in adults.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2008

Guideline

Evidence‑Based Recommendations for Diagnosing Insomnia Disorder

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Evaluating DSM-5 Insomnia Disorder and the Treatment of Sleep Problems in a Psychiatric Population.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2018

Guideline

behavioral and psychological treatments for chronic insomnia disorder in adults: an american academy of sleep medicine systematic review, meta-analysis, and grade assessment.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2021

Related Questions

For a 46-year-old woman with six months of difficulty falling asleep (≈60 minute sleep latency), early morning awakening unrefreshed, irritability and concentration problems, and no identifiable triggers, which next step is appropriate?
In a 50‑year‑old woman with a history of endocrine disease on levothyroxine (Synthroid) and irritable bowel syndrome (IBS) who experiences early‑morning awakenings with difficulty returning to sleep, no snoring or apneic symptoms, and desires a sleep study but prefers a sleep aid, what is the appropriate evaluation and management?
What blood work is recommended for diagnosing insomnia (sleep disorder)?
Does a 10‑week history of insomnia symptoms (difficulty falling asleep three nights per week, 1–2 hour sleep latency, early‑morning awakening, daytime fatigue, and no signs of obstructive sleep apnea) qualify as acute (sub‑acute) insomnia rather than chronic insomnia?
What are the differential diagnoses for insomnia?
Can a patient with asthma and a viral upper‑respiratory‑tract infection safely take ibuprofen (Nurofen), or should it be avoided?
What analgesic regimen is appropriate for a woman with a large uterine mass who is experiencing pain?
What is the first-line treatment for kleptomania?
What are the normal intervals between uterine contractions during each stage of term labor?
How does prolonged ultraviolet (UV) radiation exposure increase risk of malignant melanoma, and what are the recommended prevention, screening, and treatment strategies?
What is the appropriate glycated hemoglobin A1c (HbA1c) target for an 83‑year‑old patient with type 2 diabetes mellitus (type 2 DM) who is already reasonably controlled?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.